Blood markers in panic disorder
Part of Mental health clinical trials.
This study looks at certain blood markers (IL-33, sST2, and CRP) in people with panic disorder to see if they are different from healthy individuals. It may help researchers understand more about panic disorder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with panic disorder and have had panic attack symptoms
- You have never taken any psychiatric medications before
- You do not have another active psychiatric condition right now
- You do not have high blood pressure, diabetes, kidney or liver failure, a brain disease, an active infection, are not pregnant, do not have an autoimmune disease or cancer
- You have not taken any medications or supplements in the last month, and your BMI is between 18.5 and 29.9
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors might affect how well people with anxiety disorders respond to treatment. It also includes a healthy control group for comparison. The goal is to learn more about anxiety and how to treat it better.
This study looks at “biopsychosocial markers” (biological, psychological, and social signs) in people with major depression and/or anxiety. It aims to understand what changes with treatment and how those changes connect to symptoms like anxiety and depression.
This study looks at how social factors and blood markers relate to psychiatric symptoms in people with brain diseases or mental disorders. It aims to find new ways to understand and diagnose these conditions.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
This study examines new blood markers to predict blood clot and bleeding risks in patients with heart disease taking blood thinners. Understanding these markers may help doctors better predict complications and adjust treatment for individual patients.
This study looks at physical, immune, and brain-related “markers” in children with PANS and compares them with healthy children. It may help doctors understand what is happening in PANS and how to recognize it more clearly early on.
Hear when a new Panic Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.